Veracyte (VCYT) Return on Capital Employed (2013 - 2026)
Veracyte (VCYT) posted quarterly Return on Capital Employed of 7.56% for Q2 2026, up 646.0% year-over-year from 1.01% in Q2 2025, and up 33.17% on a QoQ basis from 5.68% in Q1 2026.
Veracyte (VCYT) Return on Capital Employed (2013 - 2026) Analysis & Trends
Veracyte has reported Return on Capital Employed for 14 years, with the latest figure at 7.56% in Q2 2026.
- Return on Capital Employed for Q2 2026 came in at 7.56%, up 646.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 7.56% (up 646.0% YoY), and the FY2025 annual result was 4.47%, up 304.0% from the prior year.
- Return on Capital Employed grew to 7.56% in Q2 2026, from 5.68% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 7.56% in Q2 2026 and troughed at 8.1% in Q4 2023.
- A 5-year average of 1.6% and a median of 3.18% in 2023 frame the typical range for Return on Capital Employed.
- The widest annual swing landed in 2023, when Return on Capital Employed plunged 430 bps; it then soared 944 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 3.81% in 2022, then plunged by 113 bps to 8.1% in 2023, then jumped by 116 bps to 1.34% in 2024, then soared by 226 bps to 4.35% in 2025, then surged by 74 bps to 7.56% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 7.56% in Q2 2026, 5.68% in Q1 2026, and 4.35% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.85% |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn | 7.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.56% |
| Mar 31, 2026 | 5.68% |
| Dec 31, 2025 | 4.35% |
| Sep 30, 2025 | 1.93% |
| Jun 30, 2025 | 1.10% |
| Mar 31, 2025 | 1.92% |
| Dec 31, 2024 | 1.34% |
| Sep 30, 2024 | -1.99% |
| Jun 30, 2024 | -5.88% |
| Mar 31, 2024 | -7.27% |
| Dec 31, 2023 | -8.10% |
| Sep 30, 2023 | -5.13% |
| Jun 30, 2023 | -3.06% |
| Mar 31, 2023 | -3.30% |
| Dec 31, 2022 | -3.81% |
| Sep 30, 2022 | -4.46% |
| Jun 30, 2022 | -5.00% |
| Mar 31, 2022 | -4.63% |
| Dec 31, 2021 | -7.29% |
| Sep 30, 2021 | -7.35% |